| Literature DB >> 32140752 |
Linda Collins1, Sanchutha Sathiananthamoorthy2, Jennifer Rohn2, James Malone-Lee2.
Abstract
INTRODUCTION AND HYPOTHESIS: Midstream urine (MSU) is key in assessing lower urinary tract syndrome (LUTS), but contingent on some assumptions. The aim of this study was to compare the occurrence of contamination and the quality of substrates obtained from four different collections: MSU, catheter specimen urine (CSU), a commercial MSU collecting device (Peezy) and a natural void. Contamination was quantified by differential, uroplakin-positive, urothelial cell counts.Entities:
Keywords: Catheter; Midstream; Peezy; Sample; UTI; Urine
Mesh:
Year: 2020 PMID: 32140752 PMCID: PMC7270983 DOI: 10.1007/s00192-020-04272-x
Source DB: PubMed Journal: Int Urogynecol J ISSN: 0937-3462 Impact factor: 2.894
Fig. 1a Illustration of the fact that the cellular sediment collects at the bladder base under the influence of gravity. A catheter passes through this sediment to obtain a specimen from the urine that is above this substrate. The sequence in b–e illustrates the phases of the voiding processes. The inflammatory sediment is shown accumulating at the bladder neck under the influence of gravity. The first part of the stream contains the largest quantity from the sediment at the bladder neck and this reduces over the course of the voiding process
The average symptom scores and quality of life scores for patients who attended the Community Lower Urinary Tract Symptom (LUTS) Clinic with LUTS
| Participants | Mean age | Mean urgency [ | Mean pain score [ | FLUTS [ | FLUTSqol [ |
|---|---|---|---|---|---|
| Patients | 60 (SD = 12) | 16 (SD = 11) | 10 (SD = 7) | 64 (SD = 40) | 151 (SD = 75) |
Evaluation of microscopic pyuria for the midstream urine (MSU) and catheter specimen urine (CSU) samples
| Analysis | Pyuria count MSU (WBCs μl−1) | Pyuria count CSU (WBCs μl−1) | |
|---|---|---|---|
| Mean | 65 | 24 | 0.001 |
| Median | 0 | 0 | |
| Standard deviation | 321 | 148 |
WBCs white blood cells
Evaluation of microscopic urinary epithelial cells for the midstream urine (MSU) and catheter specimen urine (CSU) samples
| Analysis | Epithelial cells (μl−1) MSU | Epithelial cells CSU (μl−1) | |
|---|---|---|---|
| Mean | 21 | 2 | 0.002 |
| Median | 2 | 0 | |
| Standard deviation | 103 | 4 |
Evaluation of uroplakin-positive cells (UP3) for the midstream urine (MSU) and catheter specimen urine (CSU) samples
| Analysis | UP3 cells (cells/80 μl) MSU | UP3 cells (cells/80 μl) CSU | |
|---|---|---|---|
| Mean | 17 | 5 | 0.006 |
| Median | 3 | 1 | |
| Standard deviation | 30 | 12 |
Evaluation of the proportion of uroplakin-positive cells (UP3) for the MSU and CSU sample
| Analysis | Proportion of cells UP3-positive MSU | Proportion of cells UP3-positive CSU | |
|---|---|---|---|
| Mean | 0.81 | 0.9 | 0.98 |
| Median | 1 | 1 | |
| Standard deviation | 0.3 | 0.2 |
Results of the spun urinary sediment culture carried out at the community LUTS clinic laboratory and NHS laboratory
| Number (%) culturing | Number culturing | Number culturing | Number culturing | Number culturing | Number culturing yeast | Number with no growth | Total | |
|---|---|---|---|---|---|---|---|---|
| MSU spun sediment culture, LUTS laboratory | 18 (30) | 13 (22) | 12 (20) | 5 (8) | 8 (13) | 4 (7) | 0 (0) | 60 |
| CSU spun sediment culture, LUTS laboratory | 4 (7) | 15 (26) | 1 (2) | 0 | 2 (3) | 5 (9) | 31 (53) | 58 |
| NHS MSU laboratory results | 1 (1) | 2 (2) | 1 (1) | 0 | 0 | 1 (1) | 100 (95) | 105 |
| NHS CSU laboratory results | 1 (8) | 2 (15) | 0 | 0 | 0 | 0 | 10 (77) | 13 |
Evaluation of UP3-positive cells from midstream urine (MSU), Peezy MSU™ and natural void, which are all non-invasive urine collection methods
| UP3-positive cells MSU (cells/80 μl) | UP3-positive cells Peezy MSU™ (cells/80 μl) | UP3-positive cells Natural void (cells/80 μl) | ||||
|---|---|---|---|---|---|---|
| Analysis | ||||||
| Mean | 8 | 3 | 16 | 0.001 | ||
| Median | 2 | 2 | 3 | |||
| Standard deviation | 17 | 8 | 27 | |||
| Test statistics | ||||||
| | 31 | |||||
| Chi-squared | 14.041 | |||||
| df | 2 | |||||
Evaluation of UP3-negative cells from midstream urine (MSU), Peezy MSU™ and natural void, which are all non-invasive urine collection methods
| UP3-negative cells MSU (cells/80 μl) | UP3-negative cells Peezy MSU™ (cells/80 μl) | UP3-negative cells natural void (cells/80 μl) | |||
|---|---|---|---|---|---|
| Analysis | |||||
| Mean | 1 | 0.87 | 3 | 0.325 | |
| Median | 0 | 0 | 0 | ||
| Standard deviation | 2 | 2 | 9 | ||
| Test statistics | |||||
| | 31 | ||||
| Chi-squared | 2.250 | ||||
| df | 2 | ||||
Evaluation of the proportion of UP3-positive cells from midstream urine (MSU), Peezy MSU™ and natural void, which are all non-invasive urine collection methods
| Proportion of UP3-positive cells MSU (cells/80 μl) | Proportion UP3-positive cells Peezy MSU™ (cells/80 μl) | Proportion UP3-positive cells natural void (cells/80 μl) | |||
|---|---|---|---|---|---|
| Analysis | |||||
| Mean | 0.91 | 0.88 | 0.91 | 0.5 | |
| Median | 1.0 | 1.0 | 0.97 | ||
| Standard deviation | 0.14 | 0.16 | 0.11 | ||
| Test statistics | |||||
| | 31 | ||||
| Chi-squared | 1.5 | ||||
| df | 2 | ||||